Key points:
- Salivary gland malignancies are a heterogenous and uncommon groups of
cancers.
- This is a single centre retrospective study of clinicopathological
variables that affect survival in these patients.
- PNI was present in 37% of patients.
- Five-year overall survival (OS) and disease-free survival (DFS) were
81.7% and 71%.
- Age ≥50, pT classification 3-4, high tumour grade, PNI, and advanced
TNM stage were all associated with worse OS and DFS.
- No survival difference between close or negative resection margins